Company Financials

Innovent Biologics, Inc. Financials

Hong Kong dollar

business Innovent Biologics, Inc. Company Profile

Main Stock Listing

HKEX: 1801

Market Capitalization HK$129.91 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE -1436.67
Forward PE 720.91
Price to Sales TTM HK$13.79
Price to Book MRQ HK$9.90
Enterprise to Revenue 13.10
Enterprise to EBITDA 5142.89

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin -1.00%
Operating Margin 2.85%
Return on Assets TTM -0.82%
Return on Equity TTM -0.74%

Income Statement

Revenue TTM HK$10,317,908,988
Revenue per Share TTM HK$5.79
Quarterly Revenue Growth 56.10%
Gross Profit TTM HK$7,676,804,489
EBITDA HK$252,750,000
Net Income to Common TTM HK$-103,630,408
Diluted EPS TTM HK$-0.06
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ HK$8,633,483,849
Total Cash per Share MRQ HK$4.81
Total Debt MRQ HK$
Total Debt to Equity MRQ 21.58
Current Ratio MRQ 2.35
Book Value per Share MRQ HK$8.01

Cash Flow

Operating Cash Flow TTM HK$1,409,419,982
Levered Free Cash Flow TTM HK$-123,983,936

1801 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 1,638,147,004
Float Shares 1,518,824,376
Avg 10 Volume 26,670,984
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 6.72%
% Held by Institutions 41.42%

Stock Price Summary

Beta 0.23
Fifty Two Week Low HK$28.65
Fifty Two Week High HK$87.80
Fifty Two Week Change 56.15%
Day 50 MA HK$63.66
Day 200 MA HK$45.49

Dividends and Splits

Forward Annual Dividend Rate HK$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate HK$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date